Eva Jack, Chief Business Officer at Pulmatrix, on the Promise of Biotech

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Eva Jack, Chief Business Officer at Pulmatrix, on the Promise of Biotech

Type:

Podcast

Jack discusses her greatest accomplishments, advice for industry leaders, and the promise of biotech. Pulmatrix is a clinical trial stage biotech company based in Lexington, Mass.

April 8, 2011 John Sterling, editor-in-chief of Genetic Engineering and Biotechnology News (GEN)	April 7, 2011 Countdown to Partnering With John Carroll from Fierce Biotech	March 29, 2011 Derek Gregg, Chair of BioWV and Chief Executive Officer of Vandalia Research	March 4, 2011 Dr. Lisa Beth Ferstenberg, Founding CEO of Cellective Therapeutics and a serial entrepreneur
December 8, 2010 Intellectual Property in Emerging Markets	July 29, 2010 DOE’s Assistant Secretary Zoi Announces Funding of $24 million Research Groups	June 23, 2010 BioBytes: The Biotech Drug Delivery Timeline	June 15, 2010 BioBytes: Biotechnology and Diagnostic Tools